1. Home
  2. PCRX vs ADIG Comparison

PCRX vs ADIG Comparison

Compare PCRX & ADIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

SELL

Current Price

$36.48

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Logo ADI Global Distribution Inc. Common Stock

ADIG

ADI Global Distribution Inc. Common Stock

HOLD

Current Price

$9.30

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
ADIG
Founded
2006
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
PCRX
ADIG
Price
$36.48
$9.30
Analyst Decision
Hold
Buy
Analyst Count
9
5
Target Price
★ $33.57
$16.20
AVG Volume (30 Days)
★ 958.5K
744.6K
Earning Date
11-09-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 107.44
N/A
EPS
★ 0.89
N/A
Revenue
★ $541,533,000.00
N/A
Revenue This Year
$3.84
$3.08
Revenue Next Year
$4.73
$2.24
P/E Ratio
$40.96
★ N/A
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$9.06
52 Week High
$36.67
$30.99

Technical Indicators

Market Signals
Indicator
PCRX
ADIG
Relative Strength Index (RSI) 82.40 22.56
Support Level $22.00 N/A
Resistance Level $36.67 $22.31
Average True Range (ATR) 0.04 1.30
MACD -0.37 -0.87
Stochastic Oscillator 90.00 3.55

Price Performance

Historical Comparison
PCRX
ADIG

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ADIG ADI Global Distribution Inc. Common Stock

ADI Global Distribution Inc is a specialty distributor of professionally installed low-voltage products, including security and audio-visual (AV) solutions, serving commercial and residential markets through an omnichannel go-to-market platform. It sells to professional installers, dealers, and integrators. The company's product portfolio includes products from third-party suppliers across low-voltage categories, as well as products and services offered under its own brands. Its customer base includes independent contractors, systems integrators, and low-voltage specialists serving business, institutional, and residential end users.

Share on Social Networks: